saplin

Compare funds

HSBC Value vs UTI Value

Both are value fund funds. Over the last 3 years HSBC Value returned 15.9% a year and UTI Value 13.4%, against a category median of 13.4%. HSBC Value costs 0.87% a year and UTI Value 1.34%. On the saplin Score HSBC Value rates 8.5 (Strong) and UTI Value 7.0 (Neutral) within their category. 30.6% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

HSBC ValueUTI ValueCategory median
saplin Score (0–10)8.5 Strong7.0 Neutral—
1-year return3.3%-1.3%1.0%
3-year return, a year15.9%13.4%13.4%
5-year return, a year—11.1%13.0%
Volatility (standard deviation)17.1%15.4%15.8%
Sharpe ratio0.610.490.49
Beta1.020.940.96
Upside capture11499100
Downside capture1039495
Expense ratio (Direct)0.87%1.34%1.17%
Fund size₹15,096 cr₹9,537 cr₹1,804 cr
Number of holdings846362
Top 10 holdings, share of fund30.9%42.8%37.9%
Portfolio P/E18.620.720.7
Lead managerVenugopal Manghat (14 yrs)Amit Premchandani (5 yrs)—
Launched8 Jan 201020 Jul 2005—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

HSBC Value and UTI Value have 30.6% of their portfolios in the same stocks (20 holdings in common, portfolios as of 31 Aug 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsHSBC ValueUTI Value
ICICI Bank4.20%6.66%
HDFC Bank4.15%7.83%
State Bank of India3.17%3.32%
Reliance Industries2.79%2.40%
Tech Mahindra1.99%2.89%
Larsen & Toubro2.16%1.72%
Maruti Suzuki India1.49%1.78%
Bharti Airtel1.22%4.78%
Axis Bank1.19%3.93%
NTPC1.55%1.13%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.